Scott Gottlieb and Mitch Zeller recently published an article in The New England Journal of Medicine further discussing their plans for focusing on nicotine in the Center for Tobacco Control’s new regulatory framework.
They say many of the same things Gottlieb and the FDA have already stated, like that their two primary goals are; 1) to reduce the addictiveness in combustible cigarettes and 2) to recognize the role that less harmful products can play in improving health.